Cargando…

Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation

AIMS: Cardiac cachexia is a wasting syndrome characterized by chronic inflammation and high mortality. Fibroblast growth factor 21 (FGF‐21) and monocyte chemoattractant protein 1 (MCP‐1) are associated with cardiovascular disease and systemic inflammation. We investigated FGF‐21 and MCP‐1 in relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Refsgaard Holm, Maria, Christensen, Heidi, Rasmussen, Jon, Johansen, Marie Louise, Schou, Morten, Faber, Jens, Kistorp, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816069/ https://www.ncbi.nlm.nih.gov/pubmed/31429530 http://dx.doi.org/10.1002/ehf2.12502

Ejemplares similares

MON-114 Effect of Selective Mineralocorticoid Receptor Antagonist on liver Fat and Metabolism in Patients with Type 2 Diabetes: A Randomized Controlled Trail
por: Kistorp, Caroline, et al.
Publicado: (2019)

Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction
por: Christensen, Heidi M, et al.
Publicado: (2013)

Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial
por: H. Brandt-Jacobsen, Niels, et al.
Publicado: (2023)

Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study
por: Rasmussen, Jon Jarløv, et al.
Publicado: (2016)

ODP154 Reduction of Cardiac Adipose Tissue Volume with Short-Term Empagliflozin in Patients with Type 2 Diabetes: Results from the SIMPLE Randomized Clinical Trial
por: Brandt-Jacobsen, Niels, et al.
Publicado: (2022)

Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity
por: Kistorp, Caroline, et al.
Publicado: (2014)

Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve
por: Holmager, Pernille, et al.
Publicado: (2017)

Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity
por: Rasmussen, Jon J, et al.
Publicado: (2020)

Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial
por: Brandt‐Jacobsen, Niels H., et al.
Publicado: (2023)

Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study
por: Gaborit, Freja Stoltze, et al.
Publicado: (2020)

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction
por: Jensen, Jesper, et al.
Publicado: (2020)

Inflammation in Cachexia
por: Seelaender, M., et al.
Publicado: (2015)

Prevalence of early stages of heart failure in an elderly risk population: the Copenhagen Heart Failure Risk Study
por: Gaborit, Freja Stoltze, et al.
Publicado: (2019)

Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
por: Malmborg, Morten, et al.
Publicado: (2021)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
por: Nylander, Malin, et al.
Publicado: (2017)

Myokines as Possible Therapeutic Targets in Cancer Cachexia
por: Manole, Emilia, et al.
Publicado: (2018)

Cardiac cachexia
por: Lena, Alessia, et al.
Publicado: (2019)

Inflammation Based Regulation of Cancer Cachexia
por: Onesti, Jill K., et al.
Publicado: (2014)

Inflammation‐induced cholestasis in cancer cachexia
por: Thibaut, Morgane M., et al.
Publicado: (2020)

Chronic Inflammation in Obesity and Cancer Cachexia
por: Divella, Rosa, et al.
Publicado: (2022)

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)
por: Jürgens, Mikkel, et al.
Publicado: (2019)

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
por: Jürgens, Mikkel, et al.
Publicado: (2021)

Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)
por: Parveen, Saaima, et al.
Publicado: (2022)

Cardiac Natriuretic Peptides: Contributors to Cardiac Cachexia or Possible Anti-obesity Agents or Both?
por: Costello-Boerrigter, Lisa C.
Publicado: (2012)

Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure
por: Stoltze Gaborit, Freja, et al.
Publicado: (2016)

Possible prediction of obesity‐related liver disease in children and adolescents using indices of body composition
por: Johansen, Magnus Jung, et al.
Publicado: (2022)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

Inflammation as a Therapeutic Target in Cancer Cachexia
por: Clamon, Gerald, et al.
Publicado: (2022)

Cancer cachexia and chronic inflammation: an unbreakable bond
por: Macciò, Antonio, et al.
Publicado: (2023)

Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
por: Malmborg, Morten, et al.
Publicado: (2020)

Local control on precipitation in a fully coupled climate-hydrology model
por: Larsen, Morten A. D., et al.
Publicado: (2016)

Plant Extracts as Possible Agents for Sequela of Cancer Therapies and Cachexia
por: Lee, Jinjoo, et al.
Publicado: (2020)

The impact of inflammation and acute phase activation in cancer cachexia
por: Robinson, Tyler P., et al.
Publicado: (2023)

Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients
por: Corbee, Ronald J., et al.
Publicado: (2023)

Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
por: Roubenoff, Ronenn
Publicado: (2009)

Abstracts of the Cancer Cachexia Conference, Boston, USA, 21–23 September 2012
Publicado: (2012)

Serum Insulin-Like Factor 3 Levels Are Reduced in Former Users of Anabolic Androgenic Steroids Suggesting Persistent Impaired Leydig Cell Function
por: Rasmussen, Jon Bjarke Jarløv, et al.
Publicado: (2021)

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
Publicado: (1988)

Systemic Inflammation in Cachexia – Is Tumor Cytokine Expression Profile the Culprit?
por: de Matos-Neto, Emidio M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vj1n6lg78a2rnbbkubib26o9k3